pemetrexed

Poland

Drugs containing this active substance

  • PEMETREXED EUGIA

    The medicine is used to treat malignant tumors, such as mesothelioma of the pleura and advanced lung cancer (both as initial treatment and in cases where the disease progresses or the patient's condition has not improved after other chemotherapy).

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    pemetrexed 100 mg

    ATC: L01BA04

    Manufacturer: APL Swift Services (Malta) Ltd.

  • The medicinal product is used in the treatment of malignant tumors, such as mesothelioma and advanced lung cancer.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    pemetrexed 500 mg

    ATC: L01BA04

    Manufacturer: APL Swift Services (Malta) Ltd.

  • The medicinal product is used in the treatment of malignant tumors, such as mesothelioma (in patients who have not previously undergone chemotherapy) and in the treatment of advanced lung cancer.

    Form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    pemetrexed 500 mg

    ATC: L01BA04

    Manufacturer: APIS Labor GmbH